Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines

被引:13
作者
Brzozowski, Zdzislaw [1 ]
Saczewski, Franciszek [1 ]
Slawinski, Jaroslaw [2 ]
Sanchez, Tino [3 ]
Neamati, Nouri [3 ]
机构
[1] Med Univ Gdansk, Dept Chem Technol Drugs, PL-80416 Gdansk, Poland
[2] Med Univ Gdansk, Dept Organ Chem, PL-80416 Gdansk, Poland
[3] Univ So Calif, Dept Pharmaceut Sci, Sch Pharm, Los Angeles, CA 90089 USA
关键词
3-Aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines; Synthesis; HIV-1 integrase inhibitors; VIRUS TYPE-1 INTEGRASE; HIV; INHIBITOR; ANTICANCER; DESIGN; DRUGS;
D O I
10.1016/j.ejmech.2008.02.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines 15-28 as potential HIV-1 integrase (IN) inhibitors have been synthesized by the reduction of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines 1-14 with benzenesulfonyl hydrazide. All the compounds 15-28 inhibited IN mediated strand transfer reaction with IC50 values ranging from 3 to 30 mu M. The 3-(4-bromobenzoyl)-6-chloro-7-methyl-2,3-dihydro-1,1dioxo-1,4,2-benzodithiazine 17 with the IC50 values of 4 +/- 1 and 3 +/- 1 mu M for 3'-processing and strand transfer, respectively, was the most potent. Compound 17 as well its analogues were 5-20-fold less potent in Y99S and H114A mutants, implicating these residues as potential drug-binding site. This is a first report implicating Y99S and H114A of IN core domain in drug-binding interactions. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 20 条
[1]   Discovery of a small-molecule HIV-1 integrase inhibitor-binding site [J].
Al-Mawsawi, Laith Q. ;
Fikkert, Valery ;
Dayam, Raveendra ;
Witvrouw, Myriarn ;
Burke, Terrence R., Jr. ;
Borchers, Christoph H. ;
Neamati, Nouri .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) :10080-10085
[2]   Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines [J].
Brzozowski, Z ;
Saczewski, F ;
Sanchez, T ;
Kuo, CL ;
Gdaniec, M ;
Neamati, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (13) :3663-3672
[3]  
Brzozowski Z, 1995, Acta Pol Pharm, V52, P287
[4]  
Brzozowski Z, 1998, Acta Pol Pharm, V55, P473
[5]  
Brzozowski Z, 1995, Acta Pol Pharm, V52, P91
[6]  
Brzozowski Z, 1996, Acta Pol Pharm, V53, P269
[7]  
BRZOZOWSKI Z, 1997, ACTA POLON PHARM DRU, V53, P49
[8]   Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives [J].
Brzozowski, Zdzislaw ;
Slawinski, Jaroslaw ;
Saczewski, Franciszek ;
Sanchez, Tino ;
Neamati, Nouri .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (06) :1188-1198
[9]  
CARRUTHERS W, 2004, MODERN METHODS ORGAN, P459
[10]   New approaches toward anti-HIV chemotherapy [J].
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1297-1313